Skip to main content
. 2024 Oct 18;17(11):sfae309. doi: 10.1093/ckj/sfae309

Table 3:

AEs following tixagevimab–cilgavimab administration.

Day 0 Day 3 Day 7
Event (n = 100) (n = 100) (n = 100)
Medically attended AEs 0 0 0
Pain at the injection site 16 3 0
Fatigue 15 4 0
Fever 6 0 0
Headache 5 0 0
Nausea 1 0 0

One participant can experience multiple events.